Tolerability of veliparib (V) in combination with carboplatin (C)/paclitaxel (P) - based chemoradiotherapy (CRT) in subjects with stage III non-small cell lung cancer (NSCLC).
- Citation:
- J Clin Oncol vol 35 (15 suppl) abstr 8546
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3393
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- AbbVie Inc., Bristol-Myers Squibb, Celldex, Merck, Immunocore, Reata Pharmaceuticals
- Grants:
- Corr. Author:
- Authors:
- David E. Kozono Joseph Kamel Salama Tom Stinchcombe Jeffrey Bogart William J. Petty Michael J. Guarino Lyudmila Bazhenova James Mitchell Larner Jared Weiss Thomas A. DiPetrillo Steven J. Feigenberg Tu Xu Beibei Hu Silpa Nuthalapati Lindsey Rosenwinkel Lindsey Bensman Eric Feral Johnson Mark D. McKee Everett E. Vokes
- Networks:
- CA249, GACARES, LAPS-IL057, LAPS-MA036, LAPS-NC007, LAPS-NC010, METROMIN, NC002, NY141, PA075, RI005, VA009
- Study
- AFT-07
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: